See also this year's filing and all EDGAR filings for this company.
PDF Report 0001785530_2022_Werewolf_Therapeutics_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001785530')"} |
Graph
Absolute values for 0001785530, Werewolf Therapeutics Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 161,068,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 2,913,000 |
3 | remainder_Assets | 15,269,000 |
4 | LiabilitiesCurrent | 11,874,000 |
5 | LiabilitiesNoncurrent | 14,589,000 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 14,818,000 |
9 | ResearchAndDevelopmentExpense | 35,269,000 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 104,000 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 179,250,000 |
1 | Liabilities | 26,463,000 |
2 | Expenses | 50,087,000 |
3 | Revenues | 0 |
4 | StockholdersEquity | 152,787,000 |
5 | NetIncome | -49,983,000 |
6 | ComprehensiveNetIncome | -49,983,000 |
7 | BaseVar | 127,952,000 |
8 | EconomicCapitalRatio | 2.07 |